ArticleJournal of mathematical biology2021
Dimensionality reduction via path integration for computing mRNA distributions.
Article in Journal of mathematical biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inherent stochasticity in gene expression leads to distributions of mRNA copy numbers in a population of identical cells. These distributions are determined primarily by the multitude of states of a gene promoter, each driving transcription at a different rate. In an era where single-cell mRNA copy number data are more and more available, there is an increasing need for fast computations of mRNA distributions. In this paper, we present a method for computing separate distributions for each species of mRNA molecules, i.e. mRNAs that have been either partially or fully processed post-transcription. The method involves the integration over all possible realizations of promoter states, which we cast into a set of linear ordinary differential equations of dimension [Formula: see text], where M is the number of available promoter states and [Formula: see text] is the mRNA copy number of species j up to which one wishes to compute the probability distribution. This approach is superior to solving the Master equation (ME) directly in two ways: (a) the number of coupled differential equations in the ME approach is [Formula: see text], where [Formula: see text] is the cutoff for the probability of the jth species of mRNA; and (b) the ME must be solved up to the cutoffs [Formula: see text], which must be selected a priori. In our approach, the equation for the probability to observe n mRNAs of any species depends only on the the probability of observing [Formula: see text] mRNAs of that species, thus yielding a correct probability distribution up to an arbitrary n. To demonstrate the validity of our derivations, we compare our results with Gillespie simulations for ten randomly selected system parameters.
Indexed as
Identifiers
34731323What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.